Arkolith/Insider Trading/ACAD/Form 4

Kihara James

PRINCIPAL ACCOUNTING OFFICERACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Jun 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$298K
Net Open-Market Flow
-$298K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2026Sell(S)11K$26.08$298K13K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001816160-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML